Aneuploidy index in blood: A potential marker for early onset, androgen response, and metastasis in human prostate cancer

Abstract

Objectives. To investigate whether the frequency of chromosome abnormalities in peripheral blood lymphocytes defined as the aneuploidy index in blood (AnIB) can be used as a clinical marker of early age onset, androgen response, and metastasis in human prostate cancer.